BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 4, 2020
View Archived Issues
Reservoir dogs don't hunt
Read More
Different drivers can turn the wheel in glioblastoma's vicious cycle
Read More
Phase II/III DISTINCT study of Unituxin does not meet primary endpoint
Read More
Positive top-line results from phase II WILLOW study of INS-1007
Read More
Successful completion of U.S. phase I study of liposomal annamycin in AML
Read More
HVTN702 HIV vaccine study stopped early due to non-efficacy
Read More
Safety and early signs of clinical efficacy for SBP-101 plus gemcitabine and nab-paclitaxel in PDA
Read More
First-in-human data presented for AbGn-107
Read More
9-ING-41 shows promising preliminary safety and efficacy in gastrointestinal cancers
Read More
Initial first-in-human data presented for OTL-102
Read More
Nr4a1 regulates gene transcription during cocaine abstinence: a potential target against addiction
Read More
Gedeon Richter patents nicotinic acetylcholine alpha7 receptor PAMs
Read More
Verseon divulges new thrombin inhibitors
Read More
Gilead Sciences presents PD-1/PD-L1 inhibitors
Read More
Efficacy seen in phase II study of cabozantinib in refractory metastatic colorectal cancer
Read More
Anacor Pharmaceuticals synthesizes compounds for trypanosomiasis
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group synthesizes BTK inhibitors
Read More
Nanoparticle monotherapy effective in HER2+ breast cancer in mice
Read More
FDA issues complete response letter for Luye's LY-03004 for schizophrenia and bipolar I disorder
Read More
Gerbil model of cholesteatoma developed to test oncolytic HSV potential
Read More
Active molecular changes in the BBB associated with stress resilience may protect against depression
Read More
B4GALNT1 and its products GM2/GD2 enhance tumorigenesis in melanoma by inducing angiogenesis
Read More
Aurigene initiates phase II study of AUR-101 in moderate to severe psoriasis
Read More
SBIR grant supports Plex's development of antivirals for dengue, West Nile virus and Zika
Read More
FDA approves Audenz to protect against influenza A (H5N1)
Read More